GE HealthCare Technologies Inc. Strengthens Shareholder Value with $0.03 Cash Dividend for Q2 2024 | CSIMarket News

GE HealthCare Technologies Inc. Strengthens Shareholder Value with $0.03 Cash Dividend for Q2 2024

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

GE HealthCare Continues to Deliver Dividends to Shareholders, Declares $0.03 Cash Dividend for Second Quarter of 2024

CHICAGO - In a recent press release, GE HealthCare Technologies Inc.(Nasdaq: GEHC) announced a cash dividend of $0.03 per share of Common Stock for the second quarter of 2024.This dividend is payable on August 15, 2024, to all shareholders of record as of July 19, 2024.

GE HealthCare Technologies Inc.is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics.As of the first quarter of 2024, the company’s 12-month dividend pay-out ratio has increased to 3.54, marking a new high for GE HealthCare Technologies Inc.

When compared to its peers in the healthcare sector, GE HealthCare Technologies Inc.ranks among the top companies, with 40 companies boasting a higher 12-month dividend pay-out ratio.The company has also seen significant improvement in rankings, moving from 150 in the fourth quarter of 2023 to 523 currently.

This consistent performance and commitment to shareholders highlight GE HealthCare’s dedication to delivering value and returns to its investors.With a strong position in the market and a continued focus on innovation, GE HealthCare remains a key player in the healthcare industry.

Source for this article: Based on Ge Healthcare Technologies Inc ’s official statement
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#Dividend, #Nasdaq, #dividend, #GEHC, #Ge Healthcare Technologies Inc, #Medical Laboratories
Share this article:
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License